1. Home
  2. BDSX vs CLST Comparison

BDSX vs CLST Comparison

Compare BDSX & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • CLST
  • Stock Information
  • Founded
  • BDSX 2005
  • CLST 1922
  • Country
  • BDSX United States
  • CLST United States
  • Employees
  • BDSX N/A
  • CLST N/A
  • Industry
  • BDSX Precision Instruments
  • CLST
  • Sector
  • BDSX Health Care
  • CLST
  • Exchange
  • BDSX Nasdaq
  • CLST Nasdaq
  • Market Cap
  • BDSX 53.2M
  • CLST 52.5M
  • IPO Year
  • BDSX 2020
  • CLST N/A
  • Fundamental
  • Price
  • BDSX $0.43
  • CLST $13.06
  • Analyst Decision
  • BDSX Strong Buy
  • CLST
  • Analyst Count
  • BDSX 5
  • CLST 0
  • Target Price
  • BDSX $1.75
  • CLST N/A
  • AVG Volume (30 Days)
  • BDSX 4.2M
  • CLST 2.7K
  • Earning Date
  • BDSX 10-31-2025
  • CLST 10-23-2025
  • Dividend Yield
  • BDSX N/A
  • CLST N/A
  • EPS Growth
  • BDSX N/A
  • CLST N/A
  • EPS
  • BDSX N/A
  • CLST 0.58
  • Revenue
  • BDSX $76,556,000.00
  • CLST $11,354,000.00
  • Revenue This Year
  • BDSX $18.80
  • CLST N/A
  • Revenue Next Year
  • BDSX $27.76
  • CLST N/A
  • P/E Ratio
  • BDSX N/A
  • CLST $22.67
  • Revenue Growth
  • BDSX 25.70
  • CLST 164.54
  • 52 Week Low
  • BDSX $0.17
  • CLST $10.67
  • 52 Week High
  • BDSX $1.88
  • CLST $14.23
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 52.94
  • CLST 67.19
  • Support Level
  • BDSX $0.41
  • CLST $12.66
  • Resistance Level
  • BDSX $0.54
  • CLST $13.22
  • Average True Range (ATR)
  • BDSX 0.04
  • CLST 0.16
  • MACD
  • BDSX -0.00
  • CLST 0.04
  • Stochastic Oscillator
  • BDSX 30.90
  • CLST 89.75

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

Share on Social Networks: